/ TSHA
Why Did TSHA Stock Surge Today: FDA Breakthrough Therapy Designation
Taysha stock soared after its lead Rett syndrome therapy, TSHA-102, received FDA Breakthrough Therapy status.
October 02, 2025Taysha stock soared after its lead Rett syndrome therapy, TSHA-102, received FDA Breakthrough Therapy status.
October 02, 2025